The Journal of Thoracic and Cardiovascular Surgery
Volume 141, Issue 5 , Pages 1231-1237.e1, May 2011

Sutureless replacement of aortic valves with St Jude Medical mechanical valve prostheses and Nitinol attachment rings: Feasibility in long-term (90-day) pig experiments

  • Eric Berreklouw, MD, PhD

      Affiliations

    • Cardio-thoracic Surgery, Catharina Hospital, Eindhoven, The Netherlands
    • Corresponding Author InformationAddress for correspondence: Eric Berreklouw, MD, PhD, Department of Cardio-thoracic Surgery, Catharina Hospital. P.O. Box 1350, 5602 ZA, Eindhoven, The Netherlands. Phone +31-40-2398680, Fax +31-40-2440268.
  • ,
  • Bart Koene, MD

      Affiliations

    • Cardio-thoracic Surgery, Catharina Hospital, Eindhoven, The Netherlands
  • ,
  • Filip De Somer, PhD

      Affiliations

    • Laboratory Experimental Cardiac Surgery, UGent, Ghent, Belgium
  • ,
  • Stefaan Bouchez, MD

      Affiliations

    • Laboratory Experimental Cardiac Surgery, UGent, Ghent, Belgium
  • ,
  • Koen Chiers, DMV, PhD

      Affiliations

    • Laboratory of Veterinary Pathology, UGent, Merelbeke, Belgium
  • ,
  • Yves Taeymans, MD, PhD

      Affiliations

    • Laboratory Experimental Cardiac Surgery, UGent, Ghent, Belgium
  • ,
  • Guido J. Van Nooten, MD, PhD

      Affiliations

    • Laboratory Experimental Cardiac Surgery, UGent, Ghent, Belgium

Received 30 March 2010; received in revised form 13 June 2010; accepted 3 July 2010. published online 23 August 2010.

Objective

Nitinol attachment rings (devices) used to attach mechanical aortic valve prostheses suturelessly were studied in long-term (90 days) pig experiments.

Methods

The aortic valve was removed and replaced by a device around a St Jude Medical mechanical valve prosthesis in 10 surviving pigs. Supravalvular angiography was done at the end of the operation. No coumarin derivates were given.

Results

No or minimal aortic regurgitation was confirmed in all surviving pigs at the end of the operation. Total follow-up was 846 days. In 4 pigs, follow-up was shorter than 90 days (28–75 days); the other 6 pigs did reach 90 days' survival or more. Repeat angiography in 4 pigs at the end of follow-up confirmed the unchanged position of the device at the aortic annulus, without aortic regurgitation. At autopsy, in all pigs the devices proved to be well grown in at the annulus, covered with endothelium, and sometimes tissue overgrowth related to not using coumarin derivates. There was no case of para-device leakage, migration, or embolization. No damage to surrounding anatomic structures or prosthetic valves was found.

Conclusions

Nitinol attachment rings can be used to replace the aortic valve suturelessly with St Jude Medical mechanical aortic valve prostheses, without para-device leakage, migration, or damage to the surrounding tissues, in long-term pig experiments during a follow-up of 90 days or more. Refraining from anticoagulation in pigs with mechanical valve prostheses can lead to tissue overgrowth of the valve prosthesis. Further studies are needed to determine long-term feasibility of this method in human beings.

CTSNet classification: 16:53:36 28, 35, 35.2, 35.3.4

Abbreviations and Acronyms: FDA, Food and Drug Administration, LV, left ventricular, LVH, left ventricular hypertrophy, VAR, valve attachment ring

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Some parts of the prototypes of the rings and applicators were provided by Endosmart GmbH (Stutensee, Germany), St Jude Medical (Minneapolis, Minn), Vascutek-Terumo (Renfrewshire, Scotland), Jotec GmbH (Hechingen, Germany), Kiki GmbH (Malsch, Germany), and Edwards Lifesciences Ltd (Irvine, Calif).

 Disclosures: Authors have nothing to disclose with regard to commercial support.

PII: S0022-5223(10)00734-8

doi:10.1016/j.jtcvs.2010.07.014

The Journal of Thoracic and Cardiovascular Surgery
Volume 141, Issue 5 , Pages 1231-1237.e1, May 2011